This is the first study to show that, in patients with depression, a decrease in depression severity from baseline to follow-up, measured by the MADRS, was associated with lower GR sensitivity (indicated by higher logEC IL-10) at baseline and an increase in GR sensitivity (indicated by a reduction of logEC IL-10) from baseline to follow-up. Here, IL10 is linked to depressive symptom measurement.